Nuvectra Corp.
(NASDAQ : NVTR)

( )
NVTR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
0.81%441.502.4%$434.82m
ABTAbbott Laboratories
0.00%58.640.8%$378.26m
MDTMedtronic PLC
-0.03%79.460.6%$354.10m
TMOThermo Fisher Scientific Inc.
0.00%214.521.0%$296.15m
BDXBecton, Dickinson and Company
0.00%229.431.1%$263.13m
ALGNAlign Technology, Inc.
5.85%260.006.3%$252.82m
BSXBoston Scientific Corporation
1.12%29.761.1%$230.57m
EWEdwards Lifesciences Corporation
0.00%129.601.2%$211.37m
BAXBaxter International Inc.
2.28%68.101.7%$201.71m
SYKStryker Corporation
0.00%165.391.3%$192.05m
ABMDABIOMED, Inc.
0.00%293.203.3%$127.66m
ZBHZimmer Biomet Holdings, Inc.
-1.51%109.001.7%$123.37m
WATWaters Corporation
0.00%191.533.4%$117.83m
XRAYDENTSPLY International Inc.
0.00%49.163.0%$106.50m
COOCooper Companies, Inc.
0.00%227.632.2%$94.29m

Company Profile

Nuvectra Corp. engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra, and NeuroNexus segments. The Nuvectra segmeng is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The NeuroNexus segment designs, manufacture and markets neural-interface technologies for the neuroscience clinical research market. The company was founded on November 14, 2008 and is headquartered in Plano, TX.